T2* Placental Magnetic Resonance Imaging in Preterm Preeclampsia: An Observational Cohort Study
- PMID: 32336233
- PMCID: PMC7682790
- DOI: 10.1161/HYPERTENSIONAHA.120.14701
T2* Placental Magnetic Resonance Imaging in Preterm Preeclampsia: An Observational Cohort Study
Abstract
Placental dysfunction underlies the cause of pregnancies complicated by preeclampsia. The use of placental magnetic resonance imaging to provide an insight into the pathophysiology of preeclampsia and thus assess its potential use to inform prognosis and clinical management was explored. In this prospective observational cohort study, 14 women with preterm preeclampsia and 48 gestation-matched controls using 3-Tesla magnetic resonance imaging at median of 31.6 weeks (interquartile range [IQR], 28.6-34.6) and 32.2 weeks (IQR, 28.6-33.8), respectively, were imaged. The acquired data included T2-weighted images and T2* maps of the placenta, the latter an indicative measure of placental oxygenation. Placentae in women with preeclampsia demonstrated advanced lobulation, varied lobule sizes, high granularity, and substantial areas of low-signal intensity on T2-weighted imaging, with reduced entire placental mean T2* values for gestational age (2 sample t test, t=7.49) correlating with a reduction in maternal PlGF (placental growth factor) concentrations (Spearman rank correlation coefficient 0.76) and increased lacunarity values (t=3.26). Median mean T2* reduced from 67 ms (IQR, 54-73) at 26.0 to 29.8 weeks' gestation to 38 ms (IQR, 28-40) at 34.0 to 37.9 weeks' gestation in the control group. In women with preeclampsia, median T2* was 23 ms (IQR, 20-23) at 26.0 to 29.8 weeks' gestation and remained low (22 ms [IQR, 20-26] at 34.0-37.8 weeks' gestation). Histological features of maternal vascular malperfusion were only found in placentae from women with preeclampsia. Placental volume did not differ between the control group and women with preeclampsia. Placental magnetic resonance imaging allows both objective quantification of placental function in vivo and elucidation of the complex mechanisms underlying preeclampsia development.
Keywords: magnetic resonance imaging; placenta; preeclampsia; pregnancy.
Figures



Comment in
-
Preeclamptic Placenta: New Insights Using Placental Magnetic Resonance Imaging.Hypertension. 2020 Jun;75(6):1412-1413. doi: 10.1161/HYPERTENSIONAHA.120.14855. Epub 2020 May 13. Hypertension. 2020. PMID: 32401645 No abstract available.
Similar articles
-
T2*-weighted placental magnetic resonance imaging: a biomarker of placental dysfunction in small-for-gestational-age pregnancies.Am J Obstet Gynecol MFM. 2022 May;4(3):100578. doi: 10.1016/j.ajogmf.2022.100578. Epub 2022 Jan 31. Am J Obstet Gynecol MFM. 2022. PMID: 35114424
-
Placental magnetic resonance imaging in chronic hypertension: A case-control study.Placenta. 2021 Jan 15;104:138-145. doi: 10.1016/j.placenta.2020.12.006. Epub 2020 Dec 13. Placenta. 2021. PMID: 33341490 Free PMC article.
-
Circulating maternal placental growth factor responses to low-molecular-weight heparin in pregnant patients at risk of placental dysfunction.Am J Obstet Gynecol. 2022 Feb;226(2S):S1145-S1156.e1. doi: 10.1016/j.ajog.2021.08.027. Epub 2021 Aug 27. Am J Obstet Gynecol. 2022. PMID: 34461078
-
Ophthalmic artery Doppler in the prediction of preeclampsia.Am J Obstet Gynecol. 2022 Feb;226(2S):S1098-S1101. doi: 10.1016/j.ajog.2020.11.039. Epub 2021 Apr 24. Am J Obstet Gynecol. 2022. PMID: 34292158 Review.
-
Combining Biomarkers to Predict Pregnancy Complications and Redefine Preeclampsia: The Angiogenic-Placental Syndrome.Hypertension. 2020 Apr;75(4):918-926. doi: 10.1161/HYPERTENSIONAHA.119.13763. Epub 2020 Feb 17. Hypertension. 2020. PMID: 32063058 Free PMC article. Review.
Cited by
-
Early pregnancy imaging predicts ischemic placental disease.Placenta. 2023 Sep 7;140:90-99. doi: 10.1016/j.placenta.2023.07.297. Epub 2023 Jul 31. Placenta. 2023. PMID: 37549442 Free PMC article.
-
Placental quantitative susceptibility mapping and T2* characteristics for predicting birth weight in healthy and high-risk pregnancies.Eur Radiol Exp. 2025 Feb 18;9(1):18. doi: 10.1186/s41747-025-00565-2. Eur Radiol Exp. 2025. PMID: 39966316 Free PMC article.
-
T2* placental MRI in pregnancies complicated with fetal congenital heart disease.Placenta. 2021 May;108:23-31. doi: 10.1016/j.placenta.2021.02.015. Epub 2021 Mar 9. Placenta. 2021. PMID: 33798991 Free PMC article.
-
Placental T2* as a measure of placental function across field strength from 0.55T to 3T.Sci Rep. 2024 Nov 19;14(1):28594. doi: 10.1038/s41598-024-77406-6. Sci Rep. 2024. PMID: 39562648 Free PMC article.
-
Genomic Selection Signals in Andean Highlanders Reveal Adaptive Placental Metabolic Phenotypes That Are Disrupted in Preeclampsia.Hypertension. 2024 Feb;81(2):319-329. doi: 10.1161/HYPERTENSIONAHA.123.21748. Epub 2023 Nov 29. Hypertension. 2024. PMID: 38018457 Free PMC article.
References
-
- Hutcheon JA, Lisonkova S, Joseph KS. Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy. Best Pract Res Clin Obstet Gynaecol. 2011;25:391–403. doi: 10.1016/j.bpobgyn.2011.01.006. - PubMed
-
- Cantwell R, Clutton-Brock T, Cooper G, Dawson A, Drife J, Garrod D, Harper A, Hulbert D, Lucas S, McClure J, et al. Saving Mothers’ lives: reviewing maternal deaths to make motherhood safer: 2006-2008. The eighth report of the confidential enquiries into maternal deaths in the United Kingdom. BJOG. 2011;118(suppl 1):1–203. doi: 10.1111/j.1471-0528.2010.02847.x. - PubMed
-
- Kingdom JC, Audette MC, Hobson SR, Windrim RC, Morgen E. A placenta clinic approach to the diagnosis and management of fetal growth restriction. Am J Obstet Gynecol. 2018;218(2s):S803–S817. doi: 10.1016/j.ajog.2017.11.575. - PubMed
-
- Cameron IL, Ord VA, Fullerton GD. Characterization of proton NMR relaxation times in normal and pathological tissues by correlation with other tissue parameters. Magn Reson Imaging. 1984;2:97–106. doi: 10.1016/0730-725x(84)90063-8. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources